(Short) MAPS Who?
Contrary to the public narrative, many Corporadelic executives agreed with Psymposia's critiques of MAPS/Lykos Therapeutics MDMA application.
Speaker: Psymposia co-founder Brian Normand on the Subliminal Jihad podcast.
Full interview: https://www.youtube.com/watch?v=I-69DgEFlVE
